Literature DB >> 24011817

Endovascular management of critical limb ischemia in renal transplant patients.

Denis Gilmore1, Martin Dib1, Amy Evenson1, Marc Schermerhorn1, Mark Wyers1, Elliot Chaikof1, Allen Hamdan2.   

Abstract

BACKGROUND: End-stage renal disease is a significant negative predictor of limb salvage and patient survival in patients with limb ischemia, but little is known of the overall effects of renal transplantation. Endovascular management may be less morbid than open surgery, but technical success and durability in these patients is not well established.
METHODS: All patients with functioning renal transplants and critical limb ischemia (CLI) treated with endovascular techniques between 2003 and 2010 were retrospectively reviewed for limb salvage, reintervention, pre- and postprocedure creatinine, and estimated glomerular filtration rate (eGFR), and overall survival. Contralateral common femoral access, low-profile techniques, and isosmolar contrast were standard for all interventions.
RESULTS: Endovascular interventions were performed on 57 limbs in 28 patients with renal transplants. Mean age was 54 years, 78% were male, 85% were diabetic, 100% were hypertensive, and 64% had a positive smoking history. All patients were treated for CLI. Treated regions included 16 iliac, 19 superficial femoral, 16 popliteal, and 12 tibial arteries, as well as 1 bypass graft with initial technical success of 100% and 0% 30-day mortality. Of all lesions, 43% required reintervention during the follow-up period, the majority in the first year. There was no significant change in eGFR or creatinine comparing pre- and post-angiogram value. Limb salvage and 1-year survival were 83% and 82%, respectively.
CONCLUSIONS: Endovascular management of CLI in renal transplant patients results in good technical success and can be accomplished without a measurable change in transplant kidney function, although it requires repeat interventions. Endovascular therapy is a reasonable first-line treatment option for this high-risk group.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24011817     DOI: 10.1016/j.avsg.2012.12.007

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.

Authors:  Zijie Wang; Haiwei Yang; Xuzhong Liu; Jingying Zhang; Zhijian Han; Jun Tao; Chunchun Zhao; Xiaobin Ju; Ruoyun Tan; Min Gu
Journal:  Med Sci Monit       Date:  2018-01-20

2.  Rate of Ipsilateral Chronic Limb-Threatening Ischemia (CLTI) After Kidney Transplantation: A Retrospective Single-Center Study.

Authors:  Abdul Kader Natour; Ziad Al Adas; Timothy Nypaver; Alexander Shepard; Mitchell Weaver; Lauren Malinzak; Anita Patel; Loay Kabbani
Journal:  Cureus       Date:  2022-05-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.